Jupiter Life Line Hospitals Ltd
JLHLJupiter Life Line Hospitals Ltd
JLHL
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 56.62 | 8.96 | 0.06% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.53 | 6.56 | 0.52% |
Forecast & Ratings
Detailed Forecast from 5 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Jupiter Life Line Hospitals Ltd operates multi-specialty hospitals in India, offering over 30 specialty treatments and promoting medical tourism.
Investor Presentation
View olderPeers
Compare with peersMax Healthcare Institute Ltd
Apollo Hospitals Enterprise Ltd
Fortis Healthcare Ltd
Global Health Ltd
Dr. Lal PathLabs Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 464.84 | 490.27 | 737.14 | 902.96 | 1,095.48 | 1,209.91 | ||||||
Raw Materials | 83.64 | 97.53 | 144.54 | 160.86 | 191.81 | 909.98 | ||||||
| Power & Fuel Cost | 16.04 | 15.76 | 15.62 | 22.84 | 23.37 | |||||||
| Employee Cost | 90.11 | 100.98 | 128.98 | 151.50 | 181.97 | |||||||
| Selling & Administrative Expenses | 126.89 | 137.56 | 204.55 | 253.27 | 308.64 | |||||||
| Operating & Other expenses | 63.67 | 67.17 | 86.25 | 104.96 | 125.56 | |||||||
EBITDA | 84.49 | 71.27 | 157.20 | 209.53 | 264.13 | 299.93 | ||||||
| Depreciation/Amortization | 25.91 | 30.74 | 36.16 | 38.56 | 42.38 | 46.44 | ||||||
| PBIT | 58.58 | 40.53 | 121.04 | 170.97 | 221.75 | 253.49 | ||||||
| Interest & Other Items | 25.69 | 38.98 | 43.94 | 42.27 | 26.34 | 4.16 | ||||||
| PBT | 32.89 | 1.55 | 77.10 | 128.70 | 195.41 | 249.33 | ||||||
| Taxes & Other Items | 3.25 | 3.85 | 25.99 | 55.80 | 18.80 | 64.29 | ||||||
| Net Income | 29.64 | -2.30 | 51.11 | 72.90 | 176.61 | 185.04 | ||||||
| EPS | 5.83 | -0.45 | 10.05 | 13.58 | 28.93 | 28.22 | ||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | ||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.04 |
Company Updates
Peers & Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Jupiter Life Line Hospitals Ltd | 59.32 | 8.96 | 0.06% |
| Max Healthcare Institute Ltd | 102.68 | 12.92 | 0.13% |
| Apollo Hospitals Enterprise Ltd | 116.14 | 14.26 | 0.22% |
| Fortis Healthcare Ltd | 89.98 | 6.30 | 0.14% |
Price Comparison
Compare JLHL with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Increased Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has increased by 2.78%
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Jupiter Life Line Hospitals Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
SBI FUNDS MANAGEMENT PVT LTD#SBI MF-SBI MAGNUM MIDCAP FUND DIRECT PL GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 3.3207% | Percentage of the fund’s portfolio invested in the stock 1.62% | Change in the portfolio weight of the stock over the last 3 months 0.19% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 52/82 (0) |
SBI Multicap Fund- Direct Plan- Growth option Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.4381% | Percentage of the fund’s portfolio invested in the stock 1.35% | Change in the portfolio weight of the stock over the last 3 months 0.12% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 37/49 (-4) |
SBI Healthcare Opportunities Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.2025% | Percentage of the fund’s portfolio invested in the stock 3.64% | Change in the portfolio weight of the stock over the last 3 months -0.12% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 9/34 (+1) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 2, 2024
Dividend/Share
₹1.00
Ex DateEx Date
Aug 2, 2024
Profit before tax (PBT) increased 66.55% to Rs 68.9 crore in Q2 FY25 as compared with Rs 41.4 crore in Q2 FY24. EBITDA stood at Rs 76.6 core in Q2 FY25, registering the growth of 23.5% as compared with Rs 62 crore in Q2 FY24. EBITDA margin was 19.2% in Q2 FY25 as against 19.5% in Q2 FY24. Ankit Thakker ED & CEO, Jupiter Life Line Hospitals, said, 'We are pleased to report a 20.5% increase in total income, reaching Rs 612.8 crore in H1FY25, up from Rs 508.4 crore in H1FY24. EBITDA rose by 22.3% to Rs 141.9 crore, compared to Rs 116.1 crore in H1FY24, while PAT grew by 9.6% to Rs 96.1 crore in H1FY25, up from Rs 87.7 crore in H1FY24. This growth has been driven by strong operational performance across all three hospitals, reflected in higher occupancy rates and increased ARPOB. In Q2FY25, we added 22 beds at our Pune hospital and are in the process of adding 75 new beds at our Indore hospital, which is expected to be operational by Q4FY25. We are focused on expanding the Jupiter brand, enhancing management professionalism, and increasing our footprint. With this regards, the construction of our Dombivli hospital is progressing on schedule. For our Pune hospitals, we are in the advanced stages of obtaining the necessary regulatory approvals. With the addition of these two new facilities, our total bed capacity will increase to around 2,200 beds, and we are currently identifying another location to raise our total capacity to approximately 2,500 beds.' Jupiter Life Line Hospitals is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India. Powered by Capital Market - Live
Net profit of Jupiter Life Line Hospitals rose 52.94% to Rs 51.51 crore in the quarter ended September 2024 as against Rs 33.68 crore during the previous quarter ended September 2023. Sales rose 22.57% to Rs 322.58 crore in the quarter ended September 2024 as against Rs 263.18 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales322.58263.18 23 OPM %23.2523.19 - PBDT83.3052.76 58 PBT68.9142.14 64 NP51.5133.68 53 Powered by Capital Market - Live
Jupiter Life Line Hospitals will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live
Net profit of Jupiter Life Line Hospitals declined 17.39% to Rs 44.61 crore in the quarter ended June 2024 as against Rs 54.00 crore during the previous quarter ended June 2023. Sales rose 18.05% to Rs 287.13 crore in the quarter ended June 2024 as against Rs 243.22 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales287.13243.22 18 OPM %22.2421.79 - PBDT71.1445.84 55 PBT60.1435.12 71 NP44.6154.00 -17 Powered by Capital Market - Live
Jupiter Life Line Hospitals will hold a meeting of the Board of Directors of the Company on 9 August 2024.Powered by Capital Market - Live
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant